Could Strontium Ranelate Have a Synergistic Role in the Treatment of Osteoporosis?
Authors:
- 1 August 2009
- journal article
- editorial
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 24 (8) , 1354-1357
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Comparative Effects of Teriparatide and Strontium Ranelate on Bone Biopsies and Biochemical Markers of Bone Turnover in Postmenopausal Women With OsteoporosisJournal of Bone and Mineral Research, 2009
- Histomorphometric and μCT Analysis of Bone Biopsies From Postmenopausal Osteoporotic Women Treated With Strontium RanelateJournal of Bone and Mineral Research, 2008
- Strontium Ranelate Treatment Improves Trabecular and Cortical Intrinsic Bone Tissue Quality, a Determinant of Bone StrengthJournal of Bone and Mineral Research, 2007
- Once-Yearly Zoledronic Acid for Treatment of Postmenopausal OsteoporosisNew England Journal of Medicine, 2007
- Theoretical Model for the Interpretation of BMD Scans in Patients Stopping Strontium Ranelate TreatmentJournal of Bone and Mineral Research, 2006
- Long-Term Strontium Ranelate Administration in Monkeys Preserves Characteristics of Bone Mineral Crystals and Degree of Mineralization of BoneJournal of Bone and Mineral Research, 2005
- Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal OsteoporosisJournal of Bone and Mineral Research, 2004
- Relationship of Early Changes in Bone Resorption to the Reduction in Fracture Risk With RisedronateJournal of Bone and Mineral Research, 2003
- The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitroBone, 1996
- An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient ratsJournal of Bone and Mineral Research, 1993